Olema (OLMA) | Financial Analysis & Statements
Olema Pharmaceuticals Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
0
Operating Income
-50.1M
Net Income
-46.1M
Balance Sheet Metrics
Total Assets
533.4M
Total Liabilities
54.9M
Shareholders Equity
478.6M
Debt to Equity
0.11
Cash Flow Metrics
Operating Cash Flow
-39.0M
Free Cash Flow
-38.3M
Revenue & Profitability Trend
Olema Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | 157.7M | 124.5M | 86.1M | 82.3M | 51.1M |
| Selling, General & Administrative | 21.0M | 17.7M | 18.8M | 24.7M | 20.4M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 178.7M | 142.3M | 105.0M | 107.0M | 71.5M |
| Operating Income | -178.7M | -142.3M | -105.0M | -107.0M | -71.5M |
| Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Non-Operating Items | |||||
| Interest Income | 16.2M | 12.7M | 8.3M | 2.2M | 442.0K |
| Interest Expense | - | - | - | - | 0 |
| Other Non-Operating Income | 23.0K | 102.0K | -19.0K | -27.0K | -47.0K |
| Pre-tax Income | -162.5M | -129.5M | -96.7M | -104.8M | -71.1M |
| Income Tax | - | - | - | - | - |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -162.5M | -129.5M | -96.7M | -104.8M | -71.1M |
| Net Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Key Metrics | |||||
| EBITDA | -178.2M | -141.9M | -104.6M | -106.6M | -71.3M |
| EPS (Basic) | - | $-2.20 | $-2.14 | $-2.62 | $-1.80 |
| EPS (Diluted) | - | $-2.20 | $-2.14 | $-2.62 | $-1.80 |
| Basic Shares Outstanding | - | 58743522 | 45247098 | 39995460 | 39524272 |
| Diluted Shares Outstanding | - | 58743522 | 45247098 | 39995460 | 39524272 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Olema Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 48.3M | 139.5M | 68.5M | 23.7M | 13.8M |
| Short-term Investments | 457.1M | 294.6M | 193.3M | 180.7M | 273.4M |
| Accounts Receivable | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other Current Assets | 1.6M | 366.0K | 1.7M | 1.5M | 223.0K |
| Total Current Assets | 515.5M | 438.5M | 266.5M | 208.9M | 290.7M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.4M | 2.1M | 3.3M | 4.0M | 4.9M |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 892.0K | 698.0K | - | 2.8M | 540.0K |
| Total Non-Current Assets | 18.0M | 12.5M | 10.4M | 6.7M | 5.3M |
| Total Assets | 533.4M | 451.0M | 276.9M | 215.6M | 295.9M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 9.3M | 4.5M | 2.7M | 374.0K | 23.0K |
| Short-term Debt | 1.1M | 1.2M | 988.0K | 1.0M | 931.0K |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | 82.0K | 206.0K |
| Total Current Liabilities | 51.8M | 41.8M | 21.6M | 16.5M | 9.0M |
| Non-Current Liabilities | |||||
| Long-term Debt | 3.1M | 257.0K | 1.4M | 1.6M | 2.4M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 3.1M | 257.0K | 1.4M | 1.6M | 2.4M |
| Total Liabilities | 54.9M | 42.0M | 23.0M | 18.1M | 11.4M |
| Equity | |||||
| Common Stock | 8.0K | 6.0K | 4.0K | 3.0K | 3.0K |
| Retained Earnings | -597.6M | -435.1M | -305.6M | -209.0M | -104.2M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 478.6M | 409.0M | 253.9M | 197.5M | 284.6M |
| Key Metrics | |||||
| Total Debt | 4.2M | 1.4M | 2.4M | 2.6M | 3.3M |
| Working Capital | 463.6M | 396.7M | 244.9M | 192.4M | 281.7M |
Balance Sheet Composition
Olema Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -162.5M | -129.5M | -96.7M | -104.8M | -71.1M |
| Depreciation & Amortization | 490.0K | 393.0K | 377.0K | 357.0K | 163.0K |
| Stock-Based Compensation | 17.6M | 22.6M | 17.3M | 18.8M | 15.9M |
| Working Capital Changes | 8.2M | 9.6M | -1.3M | 5.0M | 2.9M |
| Operating Cash Flow | -141.3M | -103.9M | -84.5M | -80.1M | -50.9M |
| Investing Activities | |||||
| Capital Expenditures | 0 | -159.0K | 14.0K | -363.0K | -1.6M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -500.7M | -395.0M | -255.6M | -213.7M | -487.0M |
| Investment Sales | 345.0M | 301.6M | 250.8M | 305.5M | 213.1M |
| Investing Cash Flow | -155.8M | -93.5M | -4.9M | 91.5M | -275.4M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | 0 |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 3.0M | - | - | - | 0 |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | 201.9M | 266.3M | 129.7M | 0 | 0 |
| Free Cash Flow | -146.7M | -104.5M | -83.7M | -82.4M | -52.3M |
| Net Change in Cash | -95.2M | 68.8M | 40.4M | 11.4M | -326.4M |
Cash Flow Trend
Olema Key Financial Ratios
Valuation Ratios
Forward P/E
-6.38
Price to Book
2.76
PEG Ratio
-6.38
Profitability Ratios
Profit Margin
0.00%
Operating Margin
0.00%
Return on Equity
-36.61%
Return on Assets
-21.42%
Financial Health
Current Ratio
9.95
Debt to Equity
0.88
Beta
2.18
Per Share Data
EPS (TTM)
$-1.87
Book Value per Share
$5.88
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| OLMA | 1.3B | - | 2.76 | -36.61% | 0.00% | 0.88 |
| Vertex | 109.4B | 28.40 | 5.92 | 22.54% | 32.94% | 10.91 |
| Regeneron | 81.0B | 18.00 | 2.45 | 14.86% | 31.41% | 9.51 |
| Recursion | 1.9B | -2.44 | 1.64 | -59.54% | 4.45% | 6.89 |
| Capricor | 2.0B | -15.61 | 6.62 | -46.56% | 0.00% | 4.75 |
| Zymeworks | 2.0B | 3.79 | 7.32 | -26.72% | -76.56% | 6.80 |
Financial data is updated regularly. All figures are in the company's reporting currency.






